Table of Contents
Literature Highlights
Ipilimumab in Adjuvant Setting Prolongs Survival in Stage III Melanoma | Abstract PDF |
M. Saeed Sheikh | 1 |
FDA Corner
FDA Approves New Psoriasis Drug Taltz | Abstract PDF |
3 |
FDA Approves Zepatier for Treatment of Chronic Hepatitis C Genotypes 1 and 4 | Abstract PDF |
3-4 |
FDA Approves First Drug to Show survival Benefit in Liposarcoma | Abstract PDF |
4-5 |
LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041
Copyright © 2008 LumiText Publishing. All rights reserved.